Website stats for Firstwordpharma - firstwordpharma.com
Identifying new orphan drug opportunity With year-on-year growth outstripping that of the pharmaceutical market as a whole, sales of orphan drugs are forecast to rise to $ billion by and could account for % of total prescription drug sales. The orphan drugs sector presents investors, big pharma and biotech companies with significant commercial benefits. With major brands such as Merck's ...
firstwordpharma.com was registered 1 decade 8 years ago. It has a alexa rank of #724,453 in the world. It is a domain having .com extension. It is estimated worth of $ 1,920.00 and have a daily income of around $ 8.00. As no active threats were reported recently, firstwordpharma.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 1,210 |
| Daily Pageviews: | 2,420 |
Estimated Valuation
| Income Per Day: | $ 8.00 |
| Estimated Worth: | $ 1,920.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 724,453 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
84.207.240.117
Hosted Country:
IE
Location Latitude:
53.344Location Longitude:
-6.26719Traffic Classification
| Total Traffic: | Not Applicable |
| Direct Traffic: | Not Applicable |
| Referral Traffic: | Not Applicable |
| Search Traffic: | Not Applicable |
| Social Traffic: | Not Applicable |
| Mail Traffic: | Not Applicable |
| Display Traffic: | Not Applicable |
Search Engine Results For firstwordpharma.com
FirstWord Group | LinkedIn
Friday Five - The Pharma Week in Review. firstwordpharma.com. 9 Likes ... FirstWord Pharma. Pharmaceuticals. London, London. FirstWord HealthTech ...
FirstWord Pharma: Pharmaceutical News and Biotech News
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical ...
FirstWord Pharma: Contact Information, Journalists, and Overview ...
FirstWord Pharma supplies global news and intelligence to the pharmaceutical industry. The service provides the top industry news stories on a daily basis in a ...
Articles by Anna Bratulic | FirstWord Pharma Journalist | Muck Rack
firstwordpharma.com — Biogen has struck a deal with newly public Ginkgo Bioworks to develop a next-generation production platform for recombinant adeno- ...
FirstWord Pharmaceutical News on Apple Podcasts
... business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.
Have You Subscribed To FirstWord Pharma PLUS?
... medical conditions as well as Physician Views poll data and 7 years' worth of searchable news archives. Subscribe here! (Source: FirstWord Pharma, 2014).
Resources | Svec Executive Search
FirstWord Pharma supplies global news and intelligence to the pharmaceutical industry. The service provides the ... in their industry. www.firstwordpharma.com ...
Contact FirstWord Today - FirstWord Reports
United Kingdom W1F 9NN. [email protected]. U.S.: +1 212.220.0880. U.K.: +44 (0) 20.7665.9240. www.firstwordpharma.com · www.firstwordmedtech.
Firstword Group - Home | Facebook
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry... The ...
FirstWord Pharma: Pharma Industry News and Analysis
FirstWord Pharma - Your source for disease area news and pharma industry intelligence on biosimilars, market access, medical affairs, orphan drugs, pharma ...
Top Regulatory News Stories – Week Ending July 13, 2018 | Dennis ...
Jul 13, 2018 ... ... for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC). https:// www.firstwordpharma.com/node/1577396?tsid=28®ion_id=4.
Pharma Billion Dollar Blockbusters [Infographic] | CLD
Aug 4, 2015 ... ... Billion Dollar Blockbusters Infographic http://ctt.ec/M23sa+. Source:http://www. firstwordpharma.com/node/1300127#axzz3hUSHQ7yu ...
Tris Pharma Announces Acquisition of Park Therapeutics - Pain ...
Apr 29, 2021 ... For more information, please visit www.trispharma.com. SOURCE Tris Pharma, Inc. April 29th, 2021. https://www.firstwordpharma.com/. April 29 ...
Merck & Co. says adjuvant Keytruda hits main goal of late-stage ...
Apr 9, 2021 ... ... versus Pfizer's Sutent (sunitinib) for the first-line treatment of patients with advanced RCC. April 8th, 2021. https://www.firstwordpharma.com/.
Personalize your omnichannel marketing today and see the benefits ...
Jan 19, 2021 ... Physician survey conducted March 2020. Retrieved January 2021 at https://www. firstwordpharma.com/node/1707417 · post · share · tweet; print&n...
Episode 6: Is Anyone Following Me? — UrStoria
Sep 1, 2017 ... First Word Pharma - www.firstwordpharma.com. Apple News App - Health Filter. Seeking Alpha - www.seekingalpha.com. Wall Street Journal ...
Disruptions of neurological services, its causes and mitigation ...
May 22, 2021 ... ow.ly. FirstWord Pharma. beta.firstwordpharma.com. US pauses distribution of Lilly mAb combo to Massachusetts due to Covid-19 variant.
Proposed Treatment for ADHD Suffers Setback - Psychiatric Times
Nov 12, 2020 ... ... filings for ADHD, Parkinson's disease treatments. FirstWord Pharma. November 10, 2020. https://beta.firstwordpharma.com/story/5148683.
Quarterly sales of Merck & Co.'s Keytruda cross $2 billion for...
Jan 2, 2019 ... Analysts predict annual sales of $44.2 billion, on earnings of $4.69 per share. Source: Firstwordpharma. Link: https://www.firstwordpharma.com/ ...
firstwordpharma.com at WI. Pharma Industry News and Analysis ...
May 25, 2021 ... firstwordpharma.com at WI. FirstWord Pharma - Your source for disease area news and pharma industry intelligence on biosimilars, market ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 9 |
| H3 Headings: | 14 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 1 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-71653917-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| hours ago | 14 | 1.468 % | No |
| ago Tags | 14 | 1.468 % | No |
| Clinical Research | 9 | 0.943 % | No |
| Research RD | 9 | 0.943 % | No |
| General Practice | 6 | 0.629 % | No |
| Internal Medicine | 6 | 0.629 % | No |
| Tags Press | 5 | 0.524 % | No |
| Press Release | 5 | 0.524 % | No |
| Desk Published | 5 | 0.524 % | No |
| ViewPoints Desk | 5 | 0.524 % | No |
| Practice Internal | 5 | 0.524 % | No |
| Tags ViewPoints | 5 | 0.524 % | No |
| Ref ViewPoints | 5 | 0.524 % | No |
| 13 hours | 4 | 0.419 % | No |
| Regulatory Affairs | 4 | 0.419 % | No |
| Corporate Affairs | 4 | 0.419 % | No |
| Marketing Sales | 4 | 0.419 % | No |
| FirstWord Pharma | 4 | 0.419 % | No |
| Published 13 | 4 | 0.419 % | No |
| ViewPoints Moderna | 3 | 0.314 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Ref ViewPoints Desk Published | 5 | 0.524 % | No |
| ago Tags Press Release | 5 | 0.524 % | No |
| General Practice Internal Medicine | 5 | 0.524 % | No |
| hours ago Tags ViewPoints | 5 | 0.524 % | No |
| hours ago Tags Press | 5 | 0.524 % | No |
| 13 hours ago Tags | 4 | 0.419 % | No |
| Published 13 hours ago | 4 | 0.419 % | No |
| Moderna eyes its postCOVID | 3 | 0.314 % | No |
| ZNc3 on AstraZeneca’s tail | 3 | 0.314 % | No |
| eyes its postCOVID opportunities | 3 | 0.314 % | No |
| vaccine remains paused in | 3 | 0.314 % | No |
| as advisory panel seeks | 3 | 0.314 % | No |
| Research RD Corporate Affairs | 3 | 0.314 % | No |
| Zentalis’ ZNc3 on AstraZeneca’s | 3 | 0.314 % | No |
| – Zentalis’ ZNc3 on | 3 | 0.314 % | No |
| AACR21 “WEE1 got company” | 3 | 0.314 % | No |
| ViewPoints Moderna eyes its | 3 | 0.314 % | No |
| “WEE1 got company” – | 3 | 0.314 % | No |
| got company” – Zentalis’ | 3 | 0.314 % | No |
| company” – Zentalis’ ZNc3 | 3 | 0.314 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Thu, 15 Apr 2021 10:40:13 GMT
Server: Apache/2.2.15 (Red Hat)
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Last-Modified: Thu, 15 Apr 2021 10:40:13 GMT
Cache-Control: post-check=0, pre-check=0
Vary: Accept-Encoding,User-Agent
X-XSS-Protection: 1; mode=block
X-Frame-Options: sameorigin
Content-Security-Policy: frame-ancestors 'self';
X-Content-Type-Options: nosniff
Connection: close
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Domain Information
| Domain Registrar: |
Network Solutions, LLC
|
|---|---|
| Registration Date: | 2005-11-04 1 decade 8 years 5 months ago |
| Last Modified: | 2020-10-20 3 years 6 months 1 week ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.p16.dynect.net | |
108.59.161.16 |  United States |
| ns2.p16.dynect.net | |
108.59.162.16 | United States |
| ns3.p16.dynect.net | |
108.59.163.16 | United States |
| ns4.p16.dynect.net | |
108.59.164.16 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| firstwordpharma.com | A | 3593 |
IP: 84.207.240.117 |
| firstwordpharma.com | NS | 86400 |
Target: ns1.p16.dynect.net |
| firstwordpharma.com | NS | 86400 |
Target: ns3.p16.dynect.net |
| firstwordpharma.com | NS | 86400 |
Target: ns2.p16.dynect.net |
| firstwordpharma.com | NS | 86400 |
Target: ns4.p16.dynect.net |
| firstwordpharma.com | SOA | 3600 |
MNAME: ns1.p16.dynect.net RNAME: hostmaster.pslgroup.com Serial: 186 Refresh: 3600 Retry: 600 Expire: 604800 |
| firstwordpharma.com | MX | 3600 |
Priority: 5 Target: alt2.aspmx.l.google.com |
| firstwordpharma.com | MX | 3600 |
Priority: 10 Target: aspmx3.googlemail.com |
| firstwordpharma.com | MX | 3600 |
Priority: 1 Target: aspmx.l.google.com |
| firstwordpharma.com | MX | 3600 |
Priority: 5 Target: alt1.aspmx.l.google.com |
| firstwordpharma.com | MX | 3600 |
Priority: 10 Target: aspmx2.googlemail.com |
| firstwordpharma.com | TXT | 3600 |
TXT: google-site-verification=grzMA-9vCQC4Pf7 lZVgpgnTMG0PQ_AW8KWRHJ6DO6Uo |
| firstwordpharma.com | TXT | 3600 |
TXT: google-site-verification=Zn7g62Ocm0SnBFT nvPEvfnOScMr0a1_3GvHokqB9p8Y |
| firstwordpharma.com | TXT | 3600 |
TXT: google-site-verification=vTscWQhitRCatEJ sbNNoU1GA23gW4eJHZTz60seQH18 |
| firstwordpharma.com | TXT | 3600 |
TXT: v=spf1 a mx ip:84.207.240.152 ip:84.207.240.253 ip4:84.207.240.249 ip4:167.89.94.23 ip4:167.89.75.243 include:spf.intermedia.net include:_spf.google.com ~all |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
246116116_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.networksolutions.com
Registrar URL:
http://networksolutions.com
Updated Date:
2020-10-19T19:54:44Z
Creation Date:
2005-11-03T17:13:30Z
Registry Expiry Date:
2021-11-03T16:13:30Z
Registrar: Network Solutions,
LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.P16.DYNECT.NET
Name Server: NS2.P16.DYNECT.NET
Name
Server: NS3.P16.DYNECT.NET
Name Server:
NS4.P16.DYNECT.NET
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-04-15T10:40:09Z
Similarly Ranked Websites
SANE - Scanner Access Now Easy
Services on Alioth for the SANE project
724,455 
$ 1,920.00
Нет вредителям! - Как избавиться от вредителей
Как избавиться от вредителей
724,455 $ 1,920.00
Voetbal Website + Cms, APP en narrowcasting / ClubTV voor...
VoetbalAssist; dè beheerbare Voetbal Website Cms voor voetbalverenigingen
724,458 $ 1,920.00
Περί ΦυσιQuiz | Η Φυσική Γυμνασίου σε διαδραστικά μαθήματα και quiz
Ηλεκτρονικά μαθήματα, quiz, σημειώσεις, επαναληπτικές ερωτήσεις και βοηθητικό υλικό για τη Φυσική Α γυμνασίου, τη Φυσική Β γυμνασίου και Φυσική Γ γυμνασίου.
724,458 $ 1,920.00
کارشناس رسمی دادگستری - کارشناس رسمی دادگستری
گروه کارشناسان رسمی دادگستری، ارائه خدمات تخصصی و فنی تمامی رشته ها در کل کشور به ویژه کارشناس رسمی دادگستری راه وساختمان ونقشه برداری
724,468 $ 1,920.00